OPKO Health

About OPKO Health

OPKO Health, Inc. is a fully-integrated healthcare company dedicated to delivering next-generation solutions for serious diseases across global markets. Led by an accomplished management team with unmatched drug development experience, OPKO Health aims to advance proven technologies to transform patients' lives.

Products & Services

NGENLA™:An FDA-approved next-generation human growth hormone therapy for pediatric growth hormone deficiency, approved in over 40 markets worldwide through a partnership with Pfizer.

RAYALDEE®:A marketed therapy for specific health conditions, further details available on the therapies page.

Multispecific Therapies (Research):Research focused on advancing multispecific therapies to treat complex drivers of serious conditions like cancers and infectious diseases.

BioReference Laboratories (Diagnostics):One of the largest full-service clinical reference laboratories in the U.S., serving approximately 11 million patients annually with innovations in diagnostics for specialty areas.

Specialties

Next-generation therapies Human growth hormone treatment Multispecific therapies Oncology and infectious disease research Clinical diagnostics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 230000000 MR: - FA: 230.0 million FAN: 230000000	D: 2024-01-09 FD: 2024-01-09	1 investors
2	RT: Convertible Debt T: - FT: Convertible Debt	A: 200000000 MR: - FA: $200.0 million FAN: 200000000	D: 2024-01-04 FD: 2024-01-04	3 investors
3	RT: Convertible Senior Notes T: - FT: Convertible Senior Notes	A: 200000000 MR: - FA: $200.0 million FAN: 200000000	D: 2024-01-03 FD: 2024-01-03	3 investors

Debt Latest

2024-01-09

$230.0M

1 investor (Pro only)

Convertible Debt 2024-01-04

$200.0M

Convertible Senior Notes 2024-01-03

$200.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Phil Frost

Chief Executive Officer and Chairman

J

Jane Hsiao

Chief Technical Officer and Vice Chairman

E

Elias A. Zerhouni

President and Vice Chairman

D

Dr. Giovanni Abbadessa, M.D., Ph.D.

Chief Medical Officer, ModeX

C

Craig Allen

Chief Executive Officer, BioReference Health

H

Hans Berner

President, OPKO Health Iberoamerica

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

OPKO Health Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised